Home - Chinese Journal of Cancer Research

2024 Impact Factor of CJCR: 6.3
Journal Citation Reports ™, Clarivate Analytics

Temporal trends, disease burden and attributable risk factors of stomach and colorectal cancers among 31 countries and territories in Western Pacific region, 2000−2021

Stomach cancer (SC) and colorectal cancer (CRC) present significant public health challenges because of their high incidence and mortality. According to the International Agency for Research on Cancer (IARC), more than 968,000 new cases and nearly 660,000 deaths of SC occurred in 2022, ranking the cancer as fifth in terms of both incidence and mortality worldwide. Among the six WHO regions, the Western Pacific region (WPR) suffered from the heaviest burdens of SC and CRC.

Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 2021

Data on the global, regional and national changes in the trends of colorectal cancer (CRC) are analyzed to understand the trends in its burden, in order to assist policymakers in allocating healthcare resources and developing prevention and control strategies. Referring to the latest data from the GBD 2021, this study quantifies the impact of different factors on the global, regional, and national burden of disease associated with CRC, and focuses on the differences in the burden of CRC across different SDI regions as well as across different age groups. This study was conducted to rationally allocate medical resources and optimize preventive strategies based on the analysis of the results.

Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images

Artificial intelligence has been widely applied in analysis of medical images, including computed tomography images, endoscopic images, histological images, and organoids images. In the current research, the performance of 14 convolutional neural network models was explored for classification and prediction of endoscopic images from human stomach. The purpose is to improve diagnostic accuracy and working efficiency. By training and comparison, EfficientNetB7 revealed the best performance on two-category of gastric cancer and benign lesions, gastric ulcer and ulcerated cancer, as well as early gastric cancer and non-gastric cancer. The EfficientNetB7 was also suitable for predicting the infection of Helicobacter pylori (Hp) and non-Hp infection (noHp). Notable, the InceptionV3 model was capable of predicting perigastric lymph nodes metastasis from endoscopic images.

IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer

Non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancers, with most patients presenting with advanced or metastatic disease. Lung cancer incidence is particularly high among Asians, who constitute approximately 50% of the global cases. This study reports the results from the phase III IMpower210 study, which compared the efficacy and safety of atezolizumab monotherapy with those of docetaxel in East Asian patients with advanced or metastatic NSCLC who had experienced disease progression with platinum-based chemotherapy. IMpower210 did not meet its primary efficacy endpoint of OS in the ITT EGFR-WT or overall ITT populations. Atezolizumab was comparatively more tolerable than docetaxel, with a lower incidence of grade 3/4 TRAEs.

Plant-based dietary patterns and risk of esophageal cancer: A prospective cohort study spanning 17 years

Plant-based diets have multiple health benefits for cancers; however, little is known about the association between plant-based dietary patterns and esophageal cancer (EC). This study presents an investigation of the prospective associations among three predefined indices of plant-based dietary patterns and the risk of EC. It performed endoscopic screening for 15,709 participants aged 40−69 years from two high-risk areas of China from January 2005 to December 2009 and followed the cohort until December 31, 2022. This study proves that a healthy plant-based dietary pattern was associated with a reduced risk of EC. Emphasizing the healthiness and quality of plant-based diets may be important for preventing the development of EC.

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

‹ ›

Vol 37, No 3 (Jun 2025)

Editorial

Updates of CSCO guidelines for colorectal cancer version 2025

Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

Pages: 297-302 HTML

Original Article

Deep learning-based differentiation of benign and malignant thyroid follicular neoplasms on multiscale intraoperative frozen pathological images: A multicenter diagnostic study

Jiahui Liu, Chuanguang Xiao, Haicheng Zhang, Pengyi Yu, Qi Wang, Ziru Peng, Guohua Yu, Ping Yang, Yakui Mou, Chuanliang Jia, Hongxia Cheng, Ning Mao, Xicheng Song

Pages: 303-315 HTML

Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer

Yang Ou-Yang, Caijin Lin, Yifan Xie, Xiaoqing Song, Yi-Zhou Jiang

Pages: 316-336 HTML

Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study

Yaxin Liu, Ruyan Zhang, Xiaojia Wang, Lijun Di, Zhendong Chen, Jingfen Wang, Tao Sun, Qingshan Li, Jing Cheng, Qingyuan Zhang, Xiuwen Wang, Junye Wang, Kangsheng Gu, Shihong Wei, Shuqun Zhang, Xiangcai Wang, Ping Sun, Chunfang Hao, Aimin Zang, Yujie Li, Cuicui Han, Xiaoyan Kang, Yanling Li, Huiping Li

Pages: 337-351 HTML

Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer

Yidan Ma, Jingyu Huang, Lei He, Jun Du, Longteng Liu, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Wei Zhou, Xiaomao Xu, Li Yang, Jing Di, Changbin Zhu, Lin Li, Dongge Liu, Zheng Wang

Pages: 352-364 HTML

Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials

Yanfeng Hu, Woo Jin Hyung, Huilin Huang, Changming Huang, Han-Kwang Yang, Yihong Sun, Young-Kyu Park, Xiangqian Su, Hyuk-Joon Lee, Hui Cao, Ji Yeong An, Jiankun Hu, Wook Kim, Kuan Wang, Hyoung-Il Kim, Jian Suo, Hyung-Ho Kim, Kaixiong Tao, Seung Wan Ryu, Xianli He, Hoon Hur, Hongbo Wei, Min-Chan Kim, Seong-Ho Kong, Mingang Ying, Gyu Seok Cho, Weiguo Hu, Jin-Jo Kim, Xiaohui Du, Do Joong Park, Jiang Yu, Keun Won Ryu, Hao Liu, Young Woo Kim, Ziyu Li, Jong Won Kim, Jiafu Ji, Joo-Ho Lee, Guoxin Li, Sang-Uk Han

Pages: 365-376 HTML

Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study

Yan Pan, Linbin Lu, Xianchun Gao, Jun Yu, Sitian Dai, Ruirong Yao, Ning Han, Xinlin Wang, Abudurousuli Reyila, Shibo Wang, Junya Yan, Zhen Xu, Yuanyuan Lu, Mengbin Li, Jipeng Li, Jiayun Liu, Qingchuan Zhao, Kaichun Wu, Yongzhan Nie

Pages: 377-389 HTML

Potential impact of controlling risk factors on future liver cancer deaths in China

Mengdi Cao, Yi Teng, Qianru Li, Nuopei Tan, Jiachen Wang, Tingting Zuo, Tianyi Li, Yuanjie Zheng, Changfa Xia, Wanqing Chen

Pages: 390-403 HTML

Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers

Na Zeng, Guichen Ye, Mengchu Zheng, Guangyuan Liu, Sihan Zhang, Siyang Ma, Zhiyu Xia, Yirong Zhou, Shaogang Wang, Qidong Xia

Pages: 404-416 HTML

Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group

Qi Wen, Chuanhe Jiang, Xiaodan Liu, Yi Xia, Yilei Ma, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Xiaojun Huang, Yang Cao, Yanmin Zhao, Xiaoxia Hu, Xiaodong Mo

Pages: 417-431 HTML

Review Article

Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation

Liangjie Sun, Guo Zhao, Shuhang Wang, Ning Li

Pages: 432-445 HTML

Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance

Ji’an Zou, Shuxing Wang, Yingzhe Zhang, Wentao Tian, Ge Mai, Yiting Xu, Wenjie Xiao, Edward E. Graves, Fang Wu

Pages: 446-465 HTML

Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer

Ming Li, Renyu Zhou, Yu Qiu, Yulong Peng, Minting Liu, Xiaotan Zhang

Pages: 466-486 HTML

Editorial

Updates of CSCO guidelines for colorectal cancer version 2025

Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

Pages: 297-302 HTML

CSCO Guidelines

CSCO guidelines for colorectal cancer version 2024: Updates and discussions

Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng

Pages: 233-239 HTML

CSCO guidelines for colorectal cancer version 2023: Updates and insights

Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan

Pages: 233-238 HTML

CSCO guidelines for colorectal cancer version 2022: Updates and discussions

Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan

Pages: 67-70 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)

Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology

Pages: 289-301 HTML

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan

Pages: 302-307 HTML

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 403-407 HTML

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Pages: 117-134 HTML

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association

Pages: 197-232 HTML